3. Accelerated Drug Development

  1. Mike S. Lee

Published Online: 27 JUN 2003

DOI: 10.1002/0471218812.ch3

LC/MS Applications in Drug Development

LC/MS Applications in Drug Development

How to Cite

Lee, M. S. (2002) Accelerated Drug Development, in LC/MS Applications in Drug Development, John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/0471218812.ch3

Publication History

  1. Published Online: 27 JUN 2003
  2. Published Print: 20 FEB 2002

Book Series:

  1. Wiley-Interscience Series on Mass Spectrometry

Book Series Editors:

  1. Dominic M. Desiderio1 and
  2. Nico M. M. Nibbering2

Series Editor Information

  1. 1

    Departments of Neurology and Biochemistry, University of Tennessee Health Science Center, USA

  2. 2

    University of Amsterdam, USA

ISBN Information

Print ISBN: 9780471405207

Online ISBN: 9780471218814



  • accelerated development strategies;
  • quantitative process elements;
  • qualitative process elements;
  • process pipeline;
  • motivating factors;
  • analysis opportunities;
  • accelerated development perspectives


An accelerated drug development strategy focuses on producing drug candidates and accomplishing goals in less time than with traditional development approaches. The key elements of accelerated development strategies involve the early identification of the most promising drug candidates. Opportunity exists to expose weaknesses early in the drug development cycle and to make decisions on how to address (i.e., refine) or drop from further development. The premise of this approach focuses on maximizing return on investment via the cost-effective application of resources.